Medication info
Rivaro 4 mg Tablet (Pitavastatin Calcium Hydrate)

Rivaro 4 mg Tablet (Pitavastatin Calcium Hydrate)

Prescription medicationTabletOral
Ingredient · strength
Pitavastatin Calcium Hydrate›4mg / 1 tablet
Manufacturer / importer
JW Pharmaceutical Corp.
Appearance
Yellow round film-coated tablet with a line in the center
Packaging
100 tablets/bottle, 30 tablets (10 tablets/PTP x 3)
Approval status
Active

MFDS item code 201205253 · Approved 2012.05.31 · Insurance code 644913470

Summary

Main use
Improvement of primary hypercholesterolemia and mixed dyslipidemia
Who takes it
Adults
Adult dose
Patients should follow a standard cholesterol-lowering diet before and during treatment with this medicine. The usual initial dose for adults is 1~2 milligrams of pitavastatin calcium per dose once daily. If the LDL-cholesterol-lowering effect is insufficient, the dose may be increased to a maximum of 4 milligrams per day. Adjust the dose as appropriate according to LDL cholesterol levels, treatment goals, and patient response, at intervals of 4 weeks or more. The therapeutic effect of this medicine is maintained with continued administration.

Ingredients

Manufacturer
JW Pharmaceutical Corp.

Efficacy & effects

Improvement of primary hypercholesterolemia and mixed dyslipidemia

  • Primary hypercholesterolemia
  • heterozygous familial hypercholesterolemia
  • non-familial hypercholesterolemia
  • mixed dyslipidemia
  • elevated total cholesterol
  • LDL-cholesterol
  • Apo-B protein
  • triglyceride levels
View approved original text

This medication effectively lowers total cholesterol, LDL-cholesterol, Apo-B protein, and triglyceride levels in patients with primary hypercholesterolemia and mixed dyslipidemia, and helps to increase good cholesterol levels, HDL-cholesterol. These effects are enhanced when used alongside a dietary regimen, contributing to the improvement of blood lipid levels and reducing the risk of cardiovascular diseases. Therefore, this drug plays an important role in the treatment and prevention of dyslipidemia.

How to take

Adult dose

Patients should follow a standard cholesterol-lowering diet before and during treatment with this medicine. The usual initial dose for adults is 1~2 milligrams of pitavastatin calcium per dose once daily. If the LDL-cholesterol-lowering effect is insufficient, the dose may be increased to a maximum of 4 milligrams per day. Adjust the dose as appropriate according to LDL cholesterol levels, treatment goals, and patient response, at intervals of 4 weeks or more. The therapeutic effect of this medicine is maintained with continued administration.

Precautions

This medication should not be used in certain patients. For example, it is contraindicated in patients with allergies to any of its components, those with active liver disease, severe liver dysfunction or biliary obstruction, patients taking cyclosporine, those with myopathy, women who are pregnant or may become pregnant, nursing mothers, and children. Additionally, patients with renal dysfunction or liver impairment, those who excessively consume alcohol, patients taking fibrates or niacin, individuals with hypothyroidism, patients with a history of muscle-related diseases, the elderly, and patients with severe muscle weakness should use this drug with caution. This drug can cause various side effects such as muscle pain, weakness, liver function abnormalities, skin rashes, and thrombocytopenia. Especially, if severe muscle pain or weakness is experienced, consult a doctor immediately, and regular liver function tests should be conducted. As this medication is primarily metabolized in the liver, patients with liver diseases should adjust their dosage, and those with renal impairment have an increased risk of severe muscle damage, such as rhabdomyolysis, so caution is needed. Moreover, this medication can interact with other drugs, so it should be taken under a physician’s guidance when used in conjunction with cyclosporine, fibrates, niacin, or cholestyramine. Elderly patients have reduced physical functions, which increases the likelihood of side effects, so greater attention is required during use. Pregnant or nursing mothers should not use this drug as it can harm the fetus or baby, and dosing should be stopped immediately if pregnancy is confirmed. The safety and effectiveness of this drug in pediatric patients have not been established, and its use in children is not recommended. Adhere to the prescribed dosage when taking this medication, and swallow it intact without dividing or crushing the tablets. Lastly, this medication should be stored out of reach of children and kept in its original container to maintain its quality and safety.

Side effects

  • Abdominal pain
  • rash
  • fatigue
  • paralysis
  • itching
  • muscle pain
  • weakness
  • elevated CPK levels
  • increased myoglobin in blood and urine
  • acute renal failure
Show 83 more
  • liver dysfunction
  • jaundice
  • thrombocytopenia
  • urticaria
  • erythema
  • angioedema
  • elevated bilirubin
  • elevated cholinesterase
  • elevated AST (GOT)
  • elevated ALT (GPT)
  • elevated γ-GT
  • elevated ALP
  • elevated LDH
  • stiffness
  • drowsiness
  • insomnia
  • headache
  • heaviness in the head
  • dizziness
  • thirst
  • dyspepsia
  • abdominal bloating
  • constipation
  • stomatitis
  • vomiting
  • loss of appetite
  • glossitis
  • nausea
  • gastric discomfort
  • diarrhea
  • granulocytopenia
  • leukopenia
  • eosinophilia
  • leukocytosis
  • elevated globulin
  • positive Coombs test
  • anemia
  • frequent urination
  • elevated BUN
  • elevated serum creatinine
  • decreased aldosterone
  • elevated aldosterone
  • elevated adrenocorticotropic hormone
  • elevated cortisol
  • decreased testosterone
  • muscle cramps
  • weakness
  • palpitations
  • fatigue
  • skin pain
  • burning sensation
  • joint pain
  • edema
  • blurred vision
  • photopsia
  • hearing impairment
  • hematuria
  • elevated uric acid levels
  • elevated serum potassium and phosphorus
  • taste abnormalities
  • fatigue
  • positive antinuclear antibodies
  • sleep disorders
  • amnesia
  • depression
  • interstitial lung disease
  • sexual dysfunction
  • diabetes
  • immune-mediated necrotizing myopathy
  • myasthenia gravis
  • ocular myasthenia gravis
  • facial edema
  • arm edema
  • hypersensitivity
  • headache
  • dizziness
  • skin tingling
  • insomnia
  • appetite loss
  • elevated blood pressure
  • chest discomfort
  • weakness
  • nausea

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container that protects it from light, at room temperature between 1 to 30 degrees Celsius. Doing so will help maintain the drug's effectiveness for a longer period.

Appearance and packaging

Appearance

Yellow round film-coated tablet with a line in the center

Package unit

100 tablets/bottle, 30 tablets (10 tablets/PTP x 3)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.